Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Oncology Institute Inc

TOI ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Healthcare Facilities & Services ·

USA Small Cap Analyst: BUY

Last Close

$6.45

▲ +3.04%

Market Cap $657.36M · Vol 326.93K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$657.36M

Small Cap

Div Yield

N/A

EPS Growth

+73.33%

YoY

RSI (14)

68.00

Momentum

Beta

0.49

vs Market

52W High

$7.04

8.38% below

52W Low

$2.33

177.42% above

Volume

326.93K

Avg 573.81K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

81.93%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Oncology Institute Inc (TOI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TOI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.62%

+2.71%

+59.65%

+156.97%

YTD

+81.18%

+75.75%

+651.92%

-34.85%

Financials & Valuation

TTM · Annual

Total Revenue	$502.73M
Net Income	$-60,606,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-36.01% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	+73.33%
Outstanding Shares	101.92M

Technical Indicators

50-Day SMA	$5.40
200-Day SMA	$3.93
RSI (14)	68.00
Beta	0.49
52-Week High	$7.04
52-Week Low	$2.33

Volume Today	326.93K
Avg Daily Volume (30D)	573.81K
Relative Volume	0.57x
Volatility (10D)	124.00
Volatility (30D)	95.61
Free Float	81.93%

Analyst Consensus

BUY

Current Price $6.45

Mean Target $9.00

52W Low$2.33 52W High$7.04

Current

Target

$2.33 $7.04

Current Analyst target

+39.53% upside potential · 5 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00S5H21J0

ISINUS68236X1000

CountryUnited States of America

Sub-IndustryHealthcare Facilities & Services (NEC)

Earnings DateNov 11, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

FRE.DE Fresenius SE & Co KGaA -1.22% DGX Quest Diagnostics Inc -0.69% 4013.SE Dr Sulaiman Al Habib Medical Services Group Company SJSC -1.64% MAXHEALTH.NS Max Healthcare Institute Ltd -0.46% UHS Universal Health Services Inc -0.70%

Company Profile

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.